Related Experiment Videos
[Mumps in 1997]
1Zakład Epidemiologii Państwowego, Zakładu Higieny, Warszawa.
Abstract:
In 1997 83,558 cases of mumps were reported and attack rate of 216.3/100,000 was two times higher than in the previous year. Four percent of cases were admitted to hospitals (3,327) and the percentage of hospitalised children ranged from 0.3% in Chełm voivodeship to 12.9% in Konin voivodeship. Mostly affected were children in the age group 5 to 9 years old in which attack rates ranged from 1,602 to 2,293 per 100,000. Patients in this age group constituted 59% of total number of mumps. MMR vaccine is still not included into the national programme of immunization; instead monovalent measles vaccine is used. MMR vaccine is used on voluntary basis.
Insights
Mumps cases significantly increased in 1997, with children aged 5-9 years most affected. The measles, mumps, and rubella (MMR) vaccine is not part of the national immunization program, impacting mumps prevention efforts.
Area of Science:
- Epidemiology
- Public Health
- Immunization Practices
Context:
- In 1997, Poland reported 83,558 mumps cases, a two-fold increase from the previous year.
- The overall mumps attack rate was 216.3 per 100,000 population.
- Hospitalization rates varied significantly by region, from 0.3% to 12.9%.
Purpose:
- To analyze the epidemiology of mumps in Poland in 1997.
- To identify the most affected age groups and geographical variations in mumps incidence.
- To highlight the implications of current immunization policies on mumps control.
Summary:
- Children aged 5-9 years represented 59% of total mumps cases, with attack rates ranging from 1,602 to 2,293 per 100,000.
- Four percent of all mumps cases (3,327) required hospitalization.
- Poland's national immunization program utilizes a monovalent measles vaccine, with the measles, mumps, and rubella (MMR) vaccine available only on a voluntary basis.
Impact:
- The findings underscore the substantial burden of mumps, particularly in school-aged children.
- The data suggests a potential need to re-evaluate the national immunization strategy regarding mumps inclusion.
- Understanding these epidemiological trends is crucial for developing targeted public health interventions and improving vaccine coverage.